Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy

Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a singl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Werner Schmitz, Elena Ries, Corinna Koderer, Maximilian Friedrich Völter, Anna Chiara Wünsch, Mohamed El-Mesery, Kyra Frackmann, Alexander Christian Kübler, Christian Linz, Axel Seher
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/bab2b723715640b5ba9b5810747da43b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bab2b723715640b5ba9b5810747da43b
record_format dspace
spelling oai:doaj.org-article:bab2b723715640b5ba9b5810747da43b2021-11-11T17:06:23ZCysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy10.3390/ijms2221116301422-00671661-6596https://doaj.org/article/bab2b723715640b5ba9b5810747da43b2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11630https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a single amino acid in the diet is difficult. However, the in vivo turnover rate of cysteine is usually higher than the rate of intake through food. For this reason, every cell can enzymatically synthesize cysteine from methionine, which enables the use of specific enzymatic inhibitors. In this work, we analysed the potential of cysteine restriction (CysR) in the murine cell line L929. This study determined metabolic fingerprints using mass spectrometry (LC/MS). The profiles were compared with profiles created in an earlier work under MetR. The study was supplemented by proliferation studies using D-amino acid analogues and inhibitors of intracellular cysteine synthesis. CysR showed a proliferation inhibition potential comparable to that of MetR. However, the metabolic footprints differed significantly and showed that CysR does not induce classic LEM at the metabolic level. Nevertheless, CysR offers great potential as an alternative for decisive interventions in general and tumour metabolism at the metabolic level.Werner SchmitzElena RiesCorinna KodererMaximilian Friedrich VölterAnna Chiara WünschMohamed El-MeseryKyra FrackmannAlexander Christian KüblerChristian LinzAxel SeherMDPI AGarticlemethionine restrictioncysteine restrictionmass spectrometryLC/MScancer therapycaloric restrictionBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11630, p 11630 (2021)
institution DOAJ
collection DOAJ
language EN
topic methionine restriction
cysteine restriction
mass spectrometry
LC/MS
cancer therapy
caloric restriction
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle methionine restriction
cysteine restriction
mass spectrometry
LC/MS
cancer therapy
caloric restriction
Biology (General)
QH301-705.5
Chemistry
QD1-999
Werner Schmitz
Elena Ries
Corinna Koderer
Maximilian Friedrich Völter
Anna Chiara Wünsch
Mohamed El-Mesery
Kyra Frackmann
Alexander Christian Kübler
Christian Linz
Axel Seher
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
description Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a single amino acid in the diet is difficult. However, the in vivo turnover rate of cysteine is usually higher than the rate of intake through food. For this reason, every cell can enzymatically synthesize cysteine from methionine, which enables the use of specific enzymatic inhibitors. In this work, we analysed the potential of cysteine restriction (CysR) in the murine cell line L929. This study determined metabolic fingerprints using mass spectrometry (LC/MS). The profiles were compared with profiles created in an earlier work under MetR. The study was supplemented by proliferation studies using D-amino acid analogues and inhibitors of intracellular cysteine synthesis. CysR showed a proliferation inhibition potential comparable to that of MetR. However, the metabolic footprints differed significantly and showed that CysR does not induce classic LEM at the metabolic level. Nevertheless, CysR offers great potential as an alternative for decisive interventions in general and tumour metabolism at the metabolic level.
format article
author Werner Schmitz
Elena Ries
Corinna Koderer
Maximilian Friedrich Völter
Anna Chiara Wünsch
Mohamed El-Mesery
Kyra Frackmann
Alexander Christian Kübler
Christian Linz
Axel Seher
author_facet Werner Schmitz
Elena Ries
Corinna Koderer
Maximilian Friedrich Völter
Anna Chiara Wünsch
Mohamed El-Mesery
Kyra Frackmann
Alexander Christian Kübler
Christian Linz
Axel Seher
author_sort Werner Schmitz
title Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_short Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_full Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_fullStr Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_full_unstemmed Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_sort cysteine restriction in murine l929 fibroblasts as an alternative strategy to methionine restriction in cancer therapy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bab2b723715640b5ba9b5810747da43b
work_keys_str_mv AT wernerschmitz cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT elenaries cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT corinnakoderer cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT maximilianfriedrichvolter cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT annachiarawunsch cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT mohamedelmesery cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT kyrafrackmann cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT alexanderchristiankubler cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT christianlinz cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT axelseher cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
_version_ 1718432198800965632